Looking forward, the clinical application of ferroptosis-based therapies in PDAC hinges on overcoming several pivotal challenges
Diala Alatassi, MD, FACP Medical Reviewer Diala Alatassi, MD, is a board-certified obesity medicine specialist who is committed to providing comprehensive, compassionate, and personalized care
A French nationwide case-time-control study of completed suicides and suicide attempts found no specific risk related to prior psychiatric history or obesity during GLP-1 RA use ( 5 State of the art and future directions No clear causal mechanism linking GLP-1 RA use to suicidality has been established
For lasting results, balance is key
And for the increasing number of people seeking out these peptides regardless, allowing them to be processed in FDA-inspected facilities reduces the reliance on a murky black market fraught with its own risks